{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:11:32Z","timestamp":1760911892697,"version":"build-2065373602"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T00:00:00Z","timestamp":1707609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004482","name":"Kuwait University","doi-asserted-by":"publisher","award":["MI01-20"],"award-info":[{"award-number":["MI01-20"]}],"id":[{"id":"10.13039\/501100004482","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.cyto.2024.156546","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T11:59:22Z","timestamp":1707911962000},"page":"156546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cytokine responses to major human Cytomegalovirus antigens in mouse model"],"prefix":"10.1016","volume":"176","author":[{"given":"Sahar","family":"Essa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussain A","family":"Safar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj","family":"Raghupathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2024.156546_b0005","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.1016\/j.vaccine.2018.02.089","article-title":"Vaccination against the human cytomegalovirus","volume":"37","author":"Plotkin","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.cyto.2024.156546_b0010","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.00062-12","article-title":"The \u201csilent\u201d global burden of congenital cytomegalovirus","volume":"26","author":"Manicklal","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.cyto.2024.156546_b0015","doi-asserted-by":"crossref","first-page":"e00268","DOI":"10.1128\/CVI.00268-17","article-title":"Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection","volume":"24","author":"Schleiss","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.cyto.2024.156546_b0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fimmu.2019.00078","article-title":"Cytokine-Mediated Induction and Regulation of Tissue Damage During Cytomegalovirus Infection","volume":"10","author":"Clement","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2024.156546_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v9090249","article-title":"Die another day: Inhibition of cell death pathways by cytomegalovirus","volume":"9","author":"Brune","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.cyto.2024.156546_b0030","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.4049\/jimmunol.1800171","article-title":"Cytomegalovirus: shape-shifting the immune system","volume":"200","author":"Picarda","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2024.156546_b0035","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.4049\/jimmunol.177.10.7094","article-title":"Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells","volume":"177","author":"Boehme","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2024.156546_b0040","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3389\/fimmu.2017.00733","article-title":"Latent Cytomegalovirus (CMV) Infection Does Not Detrimentally Alter T Cell Responses in the Healthy Old, but Increased Latent CMV Carriage Is Related to Expanded CMV-Specific T Cells","volume":"8","author":"Jackson","year":"2017","journal-title":"Front, Immunol."},{"key":"10.1016\/j.cyto.2024.156546_b0045","doi-asserted-by":"crossref","first-page":"e0201249","DOI":"10.1371\/journal.pone.0201249","article-title":"IL-27 regulates the number, function, and cytotoxic program of antiviral CD4 T cells and promotes cytomegalovirus persistence","volume":"13","author":"Wehrens","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2024.156546_b0050","doi-asserted-by":"crossref","first-page":"6723","DOI":"10.4049\/jimmunol.175.10.6723","article-title":"MyD88-dependent and -independent murine cytomegalovirus sensing for IFN-alpha release and initiation of immune responses in vivo","volume":"175","author":"Delale","year":"2005","journal-title":"J Immunol."},{"key":"10.1016\/j.cyto.2024.156546_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2017.00194","article-title":"CD4 CTL, a cytotoxic subset of CD4+ T cells, their differentiation and function","volume":"8","author":"Takeuchi","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2024.156546_b0060","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nri1254","article-title":"Human CD8(+) T-cell differentiation in response to viruses","volume":"3","author":"van Lier","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2024.156546_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep19227","article-title":"Cytotoxic polyfunctionality maturation of cytomegalovirus-pp65-specific CD4+ and CD8+ T-cell responses in older adults positively correlates with response size","volume":"6","author":"Chiu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2024.156546_b0070","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/JVI.01809-09","article-title":"Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH\/gL\/UL128-131A complex","volume":"84","author":"Macagno","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2024.156546_b0075","first-page":"94002","article-title":"Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys, J.C.I","volume":"2","author":"Nelson","year":"2017","journal-title":"Insight"},{"key":"10.1016\/j.cyto.2024.156546_b0080","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/cid\/cit048","article-title":"Complex correlates of protection after vaccination","volume":"56","author":"Plotkin","year":"2013","journal-title":"Clin, Infect, Dis."},{"key":"10.1016\/j.cyto.2024.156546_b0085","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.tim.2020.04.003","article-title":"Role of Neutralizing Antibodies in CMV Infection: Implications for New Therapeutic Approaches","volume":"28","author":"Sandon\u00eds","year":"2020","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.cyto.2024.156546_b0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.coviro.2012.01.001","article-title":"Human cytomegalovirus entry into cells","volume":"2","author":"Vanarsdall","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.cyto.2024.156546_b0095","doi-asserted-by":"crossref","first-page":"e1007785","DOI":"10.1371\/journal.ppat.1007785","article-title":"Early primed KLRG1-CMV-specific T cells determine the size of the inflationary T cell pool","volume":"15","author":"Baumann","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cyto.2024.156546_b0100","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/vaccines7040152","article-title":"Vaccine vectors harnessing the power of cytomegaloviruses","volume":"7","author":"Ynga-Durand","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.cyto.2024.156546_b0105","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jinf.2016.02.008","article-title":"Use of antibodies neutralizing epithelial cell infection to diagnose patients at risk for CMV disease after transplantation","volume":"72","author":"Blanco-Lobo","year":"2016","journal-title":"J. Infect."},{"key":"10.1016\/j.cyto.2024.156546_b0110","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1099\/vir.0.000203","article-title":"Role of cytomegalovirus (CMV)-specific polyfunctional CD8+ T-cells and antibodies neutralizing virus epithelial infection in the control of CMV infection in an allogeneic stem-cell transplantation setting","volume":"9","author":"Gim\u00e9nez","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.cyto.2024.156546_b0115","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/jmv.25225","article-title":"Human cytomegalovirus (HCMV)-specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection against high HCMV viral load reactivation in solid-organ transplant recipients","volume":"9","author":"Lilleri","year":"2018","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cyto.2024.156546_b0120","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01012-18","article-title":"Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors to Elicit Potent Humoral and Cellular Immune Responses against Human Cytomegalovirus in Mice","volume":"92","author":"Chiuppesi","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2024.156546_b0125","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.4161\/hv.25750","article-title":"DNA vaccine prime followed by boost with live attenuated virus significantly improves antigen-specific T cell responses against human cytomegalovirus","volume":"9","author":"Gil","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.cyto.2024.156546_b0130","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine prevention of maternal cytomegalovirus infection","volume":"360","author":"Pass","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2024.156546_b0135","first-page":"361","article-title":"Cytomegalovirus vaccine development","volume":"325","author":"Schleiss","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.cyto.2024.156546_b0140","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S2055-6640(20)30872-4","article-title":"Cytomegalovirus vaccines under clinical development","volume":"2","author":"Schleiss","year":"2016","journal-title":"J. Virus. Erad."},{"key":"10.1016\/j.cyto.2024.156546_b0145","doi-asserted-by":"crossref","first-page":"e00300","DOI":"10.1128\/CVI.00300-16","article-title":"Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B\/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector","volume":"24","author":"Schleiss","year":"2017","journal-title":"Clin. Vaccine. Immunol."},{"key":"10.1016\/j.cyto.2024.156546_b0150","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1128\/JVI.79.4.2160-2170.2005","article-title":"Complex formation by glycoproteins M and N of human cytomegalovirus: structural and functional aspects","volume":"79","author":"Mach","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2024.156546_b0155","first-page":"3","article-title":"Cytomegalovirus genes: their structure and function","volume":"99","author":"Stenberg","year":"1995","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.cyto.2024.156546_b0160","doi-asserted-by":"crossref","first-page":"10594","DOI":"10.1128\/JVI.77.19.10594-10605.2003","article-title":"Human cytomegalovirus UL99-encoded pp28 is required for the cytoplasmic envelopment of tegument-associated capsids","volume":"77","author":"Silva","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2024.156546_b0165","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1128\/jvi.12.4.919-930.1973","article-title":"Herpes simplex virus and human cytomegalovirus replication in WI-38 cells. I. Sequence of viral replication","volume":"12","author":"Smith","year":"1973","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2024.156546_b0170","doi-asserted-by":"crossref","first-page":"10894","DOI":"10.1128\/JVI.01477-14","article-title":"Diverse specificities, phenotypes, and antiviral activities of cytomegalovirus-specific CD8+ T cells","volume":"88","author":"Jackson","year":"2014","journal-title":"J, Virol."},{"key":"10.1016\/j.cyto.2024.156546_b0175","doi-asserted-by":"crossref","first-page":"e02128","DOI":"10.1128\/JVI.02128-16","article-title":"Human Cytomegalovirus (HCMV)-Specific CD4+ T Cells Are polyfunctional and can respond to Hcmv-infected dendritic cells in vitro","volume":"91","author":"Jackson","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2024.156546_b0180","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.clim.2009.02.002","article-title":"Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host","volume":"131","author":"Lilleri","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cyto.2024.156546_b0185","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1600-6143.2003.00647.x","article-title":"Cellular immune responses to cytomegalovirus in renal transplant recipients","volume":"5","author":"Radha","year":"2005","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.cyto.2024.156546_b0190","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/jmv.21799","article-title":"Kinetics of cytomegalovirus (CMV) pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: potential implications for the management of active CMV infection","volume":"82","author":"Tormo","year":"2010","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cyto.2024.156546_b0195","doi-asserted-by":"crossref","first-page":"e00181","DOI":"10.1128\/JVI.00181-19","article-title":"Human Cytomegalovirus DNA Polymerase Subunit UL44 Antagonizes Antiviral Immune Responses by Suppressing IRF3- and NF-\u03baB-Mediated Transcription","volume":"93","author":"Fu","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2024.156546_b0200","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.3390\/ijms20153626","article-title":"Battle between Host Immune Cellular Responses and HCMV Immune Evasion","volume":"20","author":"Manandhar","year":"2019","journal-title":"Int. J. Mol. Sci"},{"key":"10.1016\/j.cyto.2024.156546_b0205","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1084\/jem.168.3.919","article-title":"Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses","volume":"168","author":"Borysiewicz","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2024.156546_b0210","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1128\/JVI.77.9.5226-5240.2003","article-title":"Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers","volume":"77","author":"Elkington","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2024.156546_b0215","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1086\/339963","article-title":"Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality and phenotype","volume":"185","author":"Khan","year":"2002","journal-title":"J Infect Dis."},{"key":"10.1016\/j.cyto.2024.156546_b0220","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2024.156546_b0225","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1128\/CVI.00090-12","article-title":"Cellular immune responses to recombinant Mycobacterium bovis BCG constructs expressing major antigens of region of difference 1 of Mycobacterium tuberculosis","volume":"20","author":"Shaban","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.cyto.2024.156546_b0230","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-3083.2010.02452.x","article-title":"DNA vaccine constructs expressing Mycobacterium tuberculosis-specific genes induce immune responses","volume":"72","author":"Hanif","year":"2010","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.cyto.2024.156546_b0235","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-3083.2010.02388.x","article-title":"Molecular cloning, expression, purification and immunological characterization of three low-molecular-weight proteins encoded by genes in genomic regions of difference of Mycobacterium tuberculosis","volume":"71","author":"Hanif","year":"2010","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.cyto.2024.156546_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2021.101495","article-title":"T helper type (Th1\/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses","volume":"70","author":"Aleebrahim-Dehkordi","year":"2022","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.cyto.2024.156546_b0245","first-page":"223","article-title":"Th1\/Th2 balance: the hypothesis, its limitations, and implications for health and disease, Altern","volume":"8","author":"Kidd","year":"2003","journal-title":"Med. Rev."},{"key":"10.1016\/j.cyto.2024.156546_b0250","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3855\/jidc.10338","article-title":"Diversity of Th1\/Th2 immunity in mice with acute lung injury induced by the H1N1 influenza virus and lipopolysaccharides","volume":"13","author":"Liu","year":"2019","journal-title":"J. Inf. Dev. Ctries."},{"key":"10.1016\/j.cyto.2024.156546_b0255","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1182\/blood-2002-08-2502","article-title":"Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease","volume":"101","author":"Gamadia","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2024.156546_b0260","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.vaccine.2018.01.029","article-title":"Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity","volume":"36","author":"John","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.cyto.2024.156546_b0265","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/(SICI)1096-9071(199603)48:3<289::AID-JMV13>3.0.CO;2-8","article-title":"IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients","volume":"48","author":"Kraat","year":"1996","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cyto.2024.156546_b0270","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2249.2007.03302.x","article-title":"Immunological response to cytomegalovirus in congenitally infected neonates","volume":"147","author":"Hassan","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cyto.2024.156546_b0275","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1016\/j.vaccine.2014.05.011","article-title":"Development of a novel, guinea pig-specific IFN-gamma ELISPOT assay and characterization of guinea pig cytomegalovirus GP83-specific cellular immune responses following immunization with a modified vaccinia virus Ankara (MVA)-vectored GP83 vaccine","volume":"32","author":"Gillis","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.cyto.2024.156546_b0280","doi-asserted-by":"crossref","unstructured":"M.R. Schleiss, J.C. Lacayo, Y. Belkaid, A. McGregor, G. Stroup, J. Rayner, et al. Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection, J. Infect. Dis. (1952007) 789-798.","DOI":"10.1086\/511982"},{"key":"10.1016\/j.cyto.2024.156546_b0285","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/viro.1994.1294","article-title":"Identification of an abundant disulfide-linked complex of glycoproteins in the envelope of guinea pig cytomegalovirus","volume":"201","author":"Britt","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.cyto.2024.156546_b0290","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/viro.1994.1333","article-title":"Cloning and characterization of the guinea pig cytomegalovirus glycoprotein B gene","volume":"202","author":"Schleiss","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.cyto.2024.156546_b0295","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2217\/fvl.13.106","article-title":"Developing a vaccine against congenital cytomegalovirus (CMV) infection: what have we learned from animal models? where should we go next?","volume":"8","author":"Schleiss","year":"2013","journal-title":"Future Virol."},{"key":"10.1016\/j.cyto.2024.156546_b0300","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000109593","article-title":"Is combined pretransplantation seropositivity of kidney transplant recipients for cytomegalovirus antigens (pp150 and pp28) a predictor for protection against infection?","volume":"17","author":"Essa","year":"2008","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.cyto.2024.156546_b0305","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.drudis.2016.03.005","article-title":"Applying lessons learned from cytomegalovirus infection in transplant patients to vaccine design","volume":"21","author":"Blanco-Lobo","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.cyto.2024.156546_b0310","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/infdis\/jiaa631","article-title":"Functional Evaluation and Genetic Evolution of Human T-Cell Responses After Vaccination with a Conditionally Replication-Defective Cytomegalovirus Vaccine","volume":"223","author":"Cox","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cyto.2024.156546_b0315","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/tid.12391","article-title":"Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation","volume":"17","author":"Gim\u00e9nez","year":"2015","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.cyto.2024.156546_b0320","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1086\/340637","article-title":"Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals","volume":"185","author":"Kern","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cyto.2024.156546_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2019.108329","article-title":"Pre-transplant assessment of pp65-specific CD4 T cell responses identifies CMV-seropositive patients treated with rATG at risk of late onset infection","volume":"211","author":"L\u00f3pez-Oliva","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cyto.2024.156546_b0330","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1086\/315445","article-title":"Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs","volume":"181","author":"Gyulai","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cyto.2024.156546_b0335","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1182\/blood-2003-06-1937","article-title":"Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T cell response in natural infection","volume":"104","author":"Manley","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2024.156546_b0340","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.4049\/jimmunol.146.8.2795","article-title":"Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression","volume":"146","author":"Riddell","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2024.156546_b0345","first-page":"397","article-title":"Human cytomegalovirus matrix protein pp150 is efficiently presented as one of target antigens for cytotoxic T lymphocyte recognition","volume":"110","author":"Li","year":"1997","journal-title":"Chin. Med. J. (engl)"},{"key":"10.1016\/j.cyto.2024.156546_b0350","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.humimm.2004.10.008","article-title":"Characterization of host immunity to cytomegalovirus pp150 (UL32)","volume":"66","author":"La Rosa","year":"2005","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.cyto.2024.156546_b0355","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/sj.gt.3301809","article-title":"Communication with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice","volume":"9","author":"Cull","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.cyto.2024.156546_b0360","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1002\/eji.200425203","article-title":"Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H","volume":"34","author":"Elkington","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2024.156546_b0365","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V90.5.1751","article-title":"Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection","volume":"90","author":"Diamond","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2024.156546_b0370","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.4049\/jimmunol.172.4.2256","article-title":"Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection","volume":"172","author":"Gibson","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2024.156546_b0375","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood-2002-03-0926","article-title":"Preclinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice","volume":"100","author":"La Rosa","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2024.156546_b0380","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1128\/JVI.78.8.3965-3976.2004","article-title":"Recombinant MVA expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of CMV","volume":"78","author":"Wang","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2024.156546_b0385","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1182\/blood-2003-10-3469","article-title":"Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells","volume":"104","author":"Wang","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2024.156546_b0390","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1128\/JVI.00883-10","article-title":"Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques","volume":"85","author":"Abel","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2024.156546_b0395","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11899-020-00557-6","article-title":"Moving Past Ganciclovir and Foscarnet: Advances in CMV Therapy","volume":"15","author":"Hakki","year":"2020","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.cyto.2024.156546_b0400","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(03)14634-X","article-title":"Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines","volume":"362","author":"Peggs","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2024.156546_b0405","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation","volume":"116","author":"Feuchtinger","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2024.156546_b0410","first-page":"473","article-title":"Use of intravenous immune globulin in addition to antiviral therapy in the treatment of CMV gastrointestinal disease in allogeneic bone marrow transplant patients: a report from the European Group for Blood and Marrow Transplantation (EBMT)","volume":"21","author":"Ljungman","year":"1998","journal-title":"Infectious Diseases Working Party of the EBMT, Bone Marrow Transplant."},{"key":"10.1016\/j.cyto.2024.156546_b0415","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/cid\/civ215","article-title":"Reduced mortality of cytomegalovirus pneumonia after hematopoietic cell transplantation due to antiviral therapy and changes in transplantation practices","volume":"61","author":"Erard","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cyto.2024.156546_b0420","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.vaccine.2009.09.135","article-title":"Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers","volume":"28","author":"Bernstein","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.cyto.2024.156546_b0425","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1128\/CVI.00662-13","article-title":"Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activity","volume":"21","author":"Kirchmeier","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.cyto.2024.156546_b0430","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1182\/blood-2016-07-729756","article-title":"MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults","volume":"129","author":"La Rosa","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2024.156546_b0435","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1099\/vir.0.025742-0","article-title":"Delineating the role of CD4+ T cells in the activation of human cytomegalovirus-specific immune responses following immunization with Ad-gBCMVpoly vaccine: implications for vaccination of immunocompromised individuals","volume":"91","author":"Zhong","year":"2010","journal-title":"J. Gen. Virol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624000498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624000498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:50:56Z","timestamp":1760910656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624000498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":87,"alternative-id":["S1043466624000498"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156546","relation":{},"ISSN":["1043-4666"],"issn-type":[{"type":"print","value":"1043-4666"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine responses to major human Cytomegalovirus antigens in mouse model","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156546","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"156546"}}